OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
EFIT.MU55

EasyMotionSkin Tec GmbH

Advanced Medical Equipment & TechnologyVerified

EasyMotionSkin Tec GmbH has a fully diluted share count of 29.2 million shares, matching its basic share count, indicating no dilution from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's revenue of 4.37 million EUR reflects its position in the Advanced Medical Equipment & Technology industry, though no profitability or return metrics are available for comparison with industry medians. The lack of financial data limits the ability to assess its performance relative to peers. Geographic and segment revenue concentration data is not disclosed, making it difficult to evaluate the company's exposure to specific markets or product lines. This opacity could pose challenges in understanding the drivers of its revenue and potential vulnerabilities. The company's growth trajectory is unclear, as no forward-looking revenue estimates or historical growth rates are provided in the available data. Without this information, it is difficult to assess the company's future prospects or its ability to scale. Risk factors include the inability to assess liquidity risk and the absence of detailed financial disclosures. The dilution risk is currently low, but the lack of comprehensive financial data means that potential dilution sources or future financing needs cannot be evaluated. Recent events or filings have not been disclosed in the available data, limiting insight into the company's operational or strategic developments.

30-day price · EFIT.MU-0.20 (-14.8%)
Low$1.10High$1.40Close$1.15As of12 May, 00:00 UTC
Profile
CompanyEasyMotionSkin Tec GmbH
TickerEFIT.MU
SectorHealthcare
BusinessHealthcare Services & Equipment
Industry groupHealthcare Services & Equipment
IndustryAdvanced Medical Equipment & Technology
AI analysis

Business. EasyMotionSkin Tec GmbH develops and sells advanced medical equipment and technology, primarily focused on innovative healthcare solutions.

Classification. The company is classified under the Healthcare economic sector, Healthcare Services & Equipment business sector, and Advanced Medical Equipment & Technology industry with a confidence level of 0.92.

EasyMotionSkin Tec GmbH has a fully diluted share count of 29.2 million shares, matching its basic share count, indicating no dilution from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. The company's revenue of 4.37 million EUR reflects its position in the Advanced Medical Equipment & Technology industry, though no profitability or return metrics are available for comparison with industry medians. The lack of financial data limits the ability to assess its performance relative to peers. Geographic and segment revenue concentration data is not disclosed, making it difficult to evaluate the company's exposure to specific markets or product lines. This opacity could pose challenges in understanding the drivers of its revenue and potential vulnerabilities. The company's growth trajectory is unclear, as no forward-looking revenue estimates or historical growth rates are provided in the available data. Without this information, it is difficult to assess the company's future prospects or its ability to scale. Risk factors include the inability to assess liquidity risk and the absence of detailed financial disclosures. The dilution risk is currently low, but the lack of comprehensive financial data means that potential dilution sources or future financing needs cannot be evaluated. Recent events or filings have not been disclosed in the available data, limiting insight into the company's operational or strategic developments.
Key takeaways
  • EasyMotionSkin Tec GmbH operates in the Advanced Medical Equipment & Technology industry with a focus on healthcare innovation.
  • The company has no dilution from stock options or convertible securities, as basic and diluted share counts are equal.
  • Liquidity risk could not be assessed due to missing balance-sheet data and no going-concern language in source documents.
  • Revenue of 4.37 million EUR is reported, but no profitability or return metrics are available for comparison with industry benchmarks.
  • No growth trajectory or historical revenue data is provided, limiting the ability to assess future performance.
  • The company's geographic and segment revenue exposure is not disclosed, reducing transparency into its business model.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyEUR
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4
FY-3$4.0M$51.4k$41.0k
FY-2$3.0M$319.7k$314.3k
FY-1$9.9M-$336.8k-$360.8k
FY0$3.8M-$1.5M-$1.7M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4
FY-3$892.7k$126.4k$168.5k
FY-2$1.4M$514.0k$308.3k
FY-1$2.9M-$581.3k$241.7k
FY0$129.2M$126.6M$11.5k
PeriodOCFCapExFCFSBC
FY-4
FY-3
FY-2
FY-1
FY0
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Advanced Medical Equipment & Technology · cohort 109 companies
MetricEFIT.MUActivity
Op margin-19.9% medp25 -150.5% · p75 8.7%
Net margin-18.4% medp25 -146.8% · p75 8.0%
Gross margin49.9% medp25 36.2% · p75 66.3%
R&D / revenue6.2% medp25 4.7% · p75 12.0%
CapEx / revenue-3.5% medp25 -7.8% · p75 -1.4%
Debt / equity14.5% medp25 0.9% · p75 54.2%
Observations
IR observations
Last actual revenue4,369,040 EUR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-11 00:23 UTC#ee797f92
Market quoteclose EUR 1.15 · shares 0.03B diluted
no public URL
2026-05-11 00:23 UTC#f6f14119
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 20:17 UTCJob: 2c439c0d